Articles:

Endothelial cell vehicles for delivery of cytotoxic genes as a gene therapy approach for carcinoma of the ovary

C Rancourt, MW Robertson, 3rd, M Wang, CK Goldman, JF Kelly, RD Alvarez, GP Siegal, and DT Curiel
Clin Cancer Res 1998 4: 265 [Abstract] [PDF]  

A prospective study of K-ras mutations in the plasma of pancreatic cancer patients

HE Mulcahy, J Lyautey, C Lederrey, X qi Chen, P Anker, EM Alstead, A Ballinger, MJ Farthing, and M Stroun
Clin Cancer Res 1998 4: 271 [Abstract] [PDF]  

Pharmacodynamics of doxorubicin in human prostate tumors

CT Chen, JL Au, and MG Wientjes
Clin Cancer Res 1998 4: 277 [Abstract] [PDF]  

Phase II trial of sequential radiation and interleukin 2 in the treatment of patients with metastatic renal cell carcinoma

BG Redman, GG Hillman, L Flaherty, J Forman, B Dezso, and GP Haas
Clin Cancer Res 1998 4: 283 [Abstract] [PDF]  

RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes

G Tallini, M Santoro, M Helie, F Carlomagno, G Salvatore, G Chiappetta, ML Carcangiu, and A Fusco
Clin Cancer Res 1998 4: 287 [Abstract] [PDF]  

Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers

S Zhang, HS Zhang, VE Reuter, SF Slovin, HI Scher, and PO Livingston
Clin Cancer Res 1998 4: 295 [Abstract] [PDF]  

Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia

MF Mitchell, G Tortolero-Luna, JJ Lee, WN Hittelman, R Lotan, JT Wharton, WK Hong, and K Nishioka
Clin Cancer Res 1998 4: 303 [Abstract] [PDF]  

Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma

CH Moskowitz, JR Glassman, D Wuest, P Maslak, L Reich, A Gucciardo, N Coady-Lyons, AD Zelenetz, and SD Nimer
Clin Cancer Res 1998 4: 311 [Abstract] [PDF]  

Phase I trial of the colloidal dispersion formulation of 9-amino-20(S)-camptothecin administered as a 72-hour continuous intravenous infusion

JP Eder, Jr, JG Supko, T Lynch, M Bryant, E Vosburgh, LN Shulman, G Xu, and DW Kufe
Clin Cancer Res 1998 4: 317 [Abstract] [PDF]  

Decreased dihydropyrimidine dehydrogenase activity in a population of patients with breast cancer: implication for 5-fluorouracil-based chemotherapy

Z Lu, R Zhang, JT Carpenter, and RB Diasio
Clin Cancer Res 1998 4: 325 [Abstract] [PDF]  

Influence of amifostine on the pharmacokinetics of cisplatin in cancer patients

AE Korst, ML van der Sterre, HE Gall, AM Fichtinger-Schepman, JB Vermorken, and WJ van der Vijgh
Clin Cancer Res 1998 4: 331 [Abstract] [PDF]  

Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer

A Loktionov, IK O'Neill, KR Silvester, JH Cummings, SJ Middleton, and R Miller
Clin Cancer Res 1998 4: 337 [Abstract] [PDF]  

Dissemination of tumor cells in patients undergoing surgery for colorectal cancer

J Weitz, P Kienle, J Lacroix, F Willeke, A Benner, T Lehnert, C Herfarth, and M von Knebel Doeberitz
Clin Cancer Res 1998 4: 343 [Abstract] [PDF]  

Sequence-dependent hematological toxicity associated with the 3-hour paclitaxel/cyclophosphamide doublet

MJ Kennedy, ML Zahurak, RC Donehower, D Noe, LB Grochow, S Sartorius, TL Chen, K Bowling, M Duerr, and EK Rowinsky
Clin Cancer Res 1998 4: 349 [Abstract] [PDF]  

Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study

SM Blaney, MN Needle, A Gillespie, JK Sato, GH Reaman, SL Berg, PC Adamson, MD Krailo, WA Bleyer, DG Poplack, and FM Balis
Clin Cancer Res 1998 4: 357 [Abstract] [PDF]  

Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique

M Behn, S Qun, W Pankow, K Havemann, and M Schuermann
Clin Cancer Res 1998 4: 361 [Abstract] [PDF]  

The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer

M Hebbar, F Revillion, MM Louchez, MO Vilain, C Fournier, J Bonneterre, and JP Peyrat
Clin Cancer Res 1998 4: 373 [Abstract] [PDF]  

Reduced expression of interleukin 6 in undifferentiated thyroid carcinoma: in vitro and in vivo studies

F Basolo, L Fiore, L Pollina, G Fontanini, PG Conaldi, and A Toniolo
Clin Cancer Res 1998 4: 381 [Abstract] [PDF]  

Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin

E Mechetner, A Kyshtoobayeva, S Zonis, H Kim, R Stroup, R Garcia, RJ Parker, and JP Fruehauf
Clin Cancer Res 1998 4: 389 [Abstract] [PDF]  

Quantitative differences in telomerase activity among malignant, premalignant, and benign ovarian lesions

S Kyo, M Takakura, M Tanaka, K Murakami, R Saitoh, H Hirano, and M Inoue
Clin Cancer Res 1998 4: 399 [Abstract] [PDF]  

Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells

E Tagliabue, C Ghirelli, P Squicciarini, P Aiello, MI Colnaghi, and S Menard
Clin Cancer Res 1998 4: 407 [Abstract] [PDF]  

Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma

CT Kuo, PJ Bostick, RF Irie, DL Morton, AJ Conrad, and DS Hoon
Clin Cancer Res 1998 4: 411 [Abstract] [PDF]  

Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma

RA Ghossein, D Coit, M Brennan, ZF Zhang, Y Wang, S Bhattacharya, A Houghton, and J Rosai
Clin Cancer Res 1998 4: 419 [Abstract] [PDF]  

Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer

Y Takahashi, CD Bucana, Y Akagi, W Liu, KR Cleary, M Mai, and LM Ellis
Clin Cancer Res 1998 4: 429 [Abstract] [PDF]  

Careful histological confirmation and microdissection reveal telomerase activity in otherwise telomerase-negative breast cancers

LA Carey, CA Hedican, GS Henderson, CB Umbricht, JS Dome, D Varon, and S Sukumar
Clin Cancer Res 1998 4: 435 [Abstract] [PDF]  

A comparison between microsatellite and quantitative PCR analyses to detect frequent p16 copy number changes in primary bladder tumors

JP Cairns, PW Chiang, S Ramamoorthy, DM Kurnit, and D Sidransky
Clin Cancer Res 1998 4: 441 [Abstract] [PDF]  

Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies

RM Mohammad, K Katato, VP Almatchy, N Wall, KZ Liu, CP Schultz, HH Mantsch, M Varterasian, and AM al-Katib
Clin Cancer Res 1998 4: 445 [Abstract] [PDF]  

Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenografts

WC Zamboni, PJ Houghton, J Thompson, PJ Cheshire, SK Hanna, LB Richmond, X Lou, and CF Stewart
Clin Cancer Res 1998 4: 455 [Abstract] [PDF]  

Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity

G Vassal, I Boland, MJ Terrier-Lacombe, AJ Watson, GP Margison, AM Venuat, J Morizet, F Parker, C Lacroix, A Lellouch-Tubiana, A Pierre-Kahn, MG Poullain, and A Gouyette
Clin Cancer Res 1998 4: 463 [Abstract] [PDF]  

Pretreatment of colon carcinoma cells with Tomudex enhances 5-fluorouracil cytotoxicity

GS Longo, J Izzo, YM Chang, WP Tong, Z Zielinski, R Gorlick, TC Chou, and JR Bertino
Clin Cancer Res 1998 4: 469 [Abstract] [PDF]  

Heterogeneity of O6-alkylguanine-DNA-alkyltransferase measured by flow cytometric analysis in blood and bone marrow mononuclear cells

L Liu, K Lee, J Schupp, ON Koc, and SL Gerson
Clin Cancer Res 1998 4: 475 [Abstract] [PDF]  

Acute in vivo resistance in high-dose therapy

BA Teicher, G Ara, SR Keyes, RS Herbst, and E Frei, 3rd
Clin Cancer Res 1998 4: 483 [Abstract] [PDF]  

High susceptibility of human cancer xenografts with higher levels of cytidine deaminase to a 2'-deoxycytidine antimetabolite, 2'-deoxy-2'-methylidenecytidine

M Miwa, H Eda, M Ura, KF Ouchi, DD Keith, LH Foley, and H Ishitsuka
Clin Cancer Res 1998 4: 493 [Abstract] [PDF]  

Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model

A Cabanes, D Tzemach, D Goren, AT Horowitz, and A Gabizon
Clin Cancer Res 1998 4: 499 [Abstract] [PDF]  

Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity

PJ Coopman, MT Do, EW Thompson, and SC Mueller
Clin Cancer Res 1998 4: 507 [Abstract] [PDF]  

bcl-2, bax, bcl-XL, and bcl-XS expression in normal and neoplastic ovarian tissues

M Marone, G Scambia, S Mozzetti, G Ferrandina, S Iacovella, A De Pasqua, P Benedetti-Panici, and S Mancuso
Clin Cancer Res 1998 4: 517 [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.